Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 294

1.

Problematic End Points in a Trial of Topical Fluorouracil, 5%, for Chemoprevention of Keratinocyte Carcinoma-Reply.

Weinstock MA, Lew RA, Shaw FM; Veterans Affairs Keratinocyte Carcinoma Chemoprevention Trial (VAKCC) Group.

JAMA Dermatol. 2018 Jun 13. doi: 10.1001/jamadermatol.2018.1230. [Epub ahead of print] No abstract available.

PMID:
29898230
2.

Psychosocial consequences of skin cancer screening.

Risica PM, Matthews NH, Dionne L, Mello J, Ferris LK, Saul M, Geller AC, Solano F, Kirkwood JM, Weinstock MA.

Prev Med Rep. 2018 Apr 17;10:310-316. doi: 10.1016/j.pmedr.2018.04.011. eCollection 2018 Jun.

3.

Complexities of perceived and actual performance in pathology interpretation: A comparison of cutaneous melanocytic skin and breast interpretations.

Carney PA, Frederick PD, Reisch LM, Titus L, Knezevich SR, Weinstock MA, Piepkorn MW, Barnhill RL, Elder DE, Weaver DL, Elmore JG.

J Cutan Pathol. 2018 Jul;45(7):478-490. doi: 10.1111/cup.13147. Epub 2018 Apr 26.

PMID:
29603324
4.

How data can deliver for dermatology.

Abuabara K, Asgari MM, Chen SC, Dellavalle RP, Kalia S, Secrest AM, Silverberg JI, Solomon JA, Weinstock MA, Wu JJ, Chren MM; Epidemiology Expert Research Group.

J Am Acad Dermatol. 2018 Mar 21. pii: S0190-9622(18)30470-5. doi: 10.1016/j.jaad.2018.03.020. [Epub ahead of print] No abstract available.

PMID:
29574090
5.

Treatments for Basal Cell and Squamous Cell Carcinoma of the Skin [Internet].

Drucker A, Adam GP, Langberg V, Gazula A, Smith B, Moustafa F, Weinstock MA, Trikalinos TA.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2017 Dec.

6.

Pathologist characteristics associated with accuracy and reproducibility of melanocytic skin lesion interpretation.

Elder DE, Piepkorn MW, Barnhill RL, Longton GM, Nelson HD, Knezevich SR, Pepe MS, Carney PA, Titus LJ, Onega T, Tosteson ANA, Weinstock MA, Elmore JG.

J Am Acad Dermatol. 2018 Jul;79(1):52-59.e5. doi: 10.1016/j.jaad.2018.02.070. Epub 2018 Mar 7.

PMID:
29524584
7.

Impact of topical fluorouracil cream on costs of treating keratinocyte carcinoma (nonmelanoma skin cancer) and actinic keratosis.

Yoon J, Phibbs CS, Chow A, Weinstock MA; Veterans Affairs Keratinocyte Carcinoma Chemoprevention Trial Group.

J Am Acad Dermatol. 2018 Mar 2. pii: S0190-9622(18)30344-X. doi: 10.1016/j.jaad.2018.02.058. [Epub ahead of print]

PMID:
29505863
8.

Epidemiology of Melanoma.

Matthews NH, Li WQ, Qureshi AA, Weinstock MA, Cho E.

In: Ward WH, Farma JM, editors. Cutaneous Melanoma: Etiology and Therapy [Internet]. Brisbane (AU): Codon Publications; 2017 Dec 21. Chapter 1.

9.

Comparing Topical Treatments for Basal Cell Carcinoma.

Shaw FM, Weinstock MA.

J Invest Dermatol. 2018 Mar;138(3):484-486. doi: 10.1016/j.jid.2017.11.024. Epub 2018 Feb 1.

PMID:
29395168
10.

Chemoprevention of Basal and Squamous Cell Carcinoma With a Single Course of Fluorouracil, 5%, Cream: A Randomized Clinical Trial.

Weinstock MA, Thwin SS, Siegel JA, Marcolivio K, Means AD, Leader NF, Shaw FM, Hogan D, Eilers D, Swetter SM, Chen SC, Jacob SE, Warshaw EM, Stricklin GP, Dellavalle RP, Sidhu-Malik N, Konnikov N, Werth VP, Keri JE, Robinson-Bostom L, Ringer RJ, Lew RA, Ferguson R, DiGiovanna JJ, Huang GD; Veterans Affairs Keratinocyte Carcinoma Chemoprevention Trial (VAKCC) Group.

JAMA Dermatol. 2018 Feb 1;154(2):167-174. doi: 10.1001/jamadermatol.2017.3631.

PMID:
29299592
11.

Interrater reliability for histopathologic diagnosis of keratinocyte carcinomas.

Leader NF, Means AD, Robinson-Bostom L, Telang GH, Wilkel CS, Weinstock MA; Veterans Affairs Keratinocyte Carcinoma Chemoprevention Trial group.

J Am Acad Dermatol. 2018 Jan;78(1):185-187. doi: 10.1016/j.jaad.2017.07.024. No abstract available.

PMID:
29241779
12.

A risk adjustment approach to estimating the burden of skin disease in the United States.

Lim HW, Collins SAB, Resneck JS Jr, Bolognia J, Hodge JA, Rohrer TA, Van Beek MJ, Margolis DJ, Sober AJ, Weinstock MA, Nerenz DR, Begolka WS, Moyano JV.

J Am Acad Dermatol. 2018 Jan;78(1):129-140. doi: 10.1016/j.jaad.2017.08.060. Epub 2017 Oct 27.

PMID:
29110889
13.

Population-Based Analysis of Histologically Confirmed Melanocytic Proliferations Using Natural Language Processing.

Lott JP, Boudreau DM, Barnhill RL, Weinstock MA, Knopp E, Piepkorn MW, Elder DE, Knezevich SR, Baer A, Tosteson ANA, Elmore JG.

JAMA Dermatol. 2018 Jan 1;154(1):24-29. doi: 10.1001/jamadermatol.2017.4060.

PMID:
29094145
14.

Tetracycline use and risk of incident skin cancer: a prospective study.

Li WQ, Drucker AM, Cho E, Laden F, VoPham T, Li S, Weinstock MA, Qureshi AA.

Br J Cancer. 2018 Jan;118(2):294-298. doi: 10.1038/bjc.2017.378. Epub 2017 Oct 26.

PMID:
29073637
15.

Effect of Topical Fluorouracil Cream on Photodamage: Secondary Analysis of a Randomized Clinical Trial.

Korgavkar K, Lee KC, Weinstock MA; Veterans Affairs Keratinocyte Carcinoma Chemoprevention (VAKCC) Trial Group.

JAMA Dermatol. 2017 Nov 1;153(11):1142-1146. doi: 10.1001/jamadermatol.2017.2578.

PMID:
28877312
16.

Pathologists' Use of Second Opinions in Interpretation of Melanocytic Cutaneous Lesions: Policies, Practices, and Perceptions.

Geller BM, Frederick PD, Knezevich SR, Lott JP, Nelson HD, Titus LJ, Carney PA, Tosteson ANA, Onega TL, Barnhill RL, Weinstock MA, Elder DE, Piepkorn MW, Elmore JG.

Dermatol Surg. 2018 Feb;44(2):177-185. doi: 10.1097/DSS.0000000000001256.

PMID:
28858936
17.

Association between risk factors and detection of cutaneous melanoma in the setting of a population-based skin cancer screening.

Hübner J, Waldmann A, Eisemann N, Noftz M, Geller AC, Weinstock MA, Volkmer B, Greinert R, Breitbart EW, Katalinic A.

Eur J Cancer Prev. 2017 Jul 7. doi: 10.1097/CEJ.0000000000000392. [Epub ahead of print]

PMID:
28692584
18.

Pathologists' diagnosis of invasive melanoma and melanocytic proliferations: observer accuracy and reproducibility study.

Elmore JG, Barnhill RL, Elder DE, Longton GM, Pepe MS, Reisch LM, Carney PA, Titus LJ, Nelson HD, Onega T, Tosteson ANA, Weinstock MA, Knezevich SR, Piepkorn MW.

BMJ. 2017 Jun 28;357:j2813. doi: 10.1136/bmj.j2813. Erratum in: BMJ. 2017 Aug 8;358:j3798.

19.

Validation and comparison of quality-of-life measures for topical 5-fluorouracil treatment: results from a randomized controlled trial.

Pomerantz H, Chren MM, Lew R, Weinstock MA; VA Keratinocyte Carcinoma Chemoprevention (VAKCC) Trial Group*.

Clin Exp Dermatol. 2017 Jul;42(5):488-495. doi: 10.1111/ced.13089.

PMID:
28621489
20.

Reply to: "Inaccuracies in SEER registry data on melanoma thickness".

Landow SM, Gjelsvik A, Weinstock MA.

J Am Acad Dermatol. 2017 Jul;77(1):e19. doi: 10.1016/j.jaad.2017.03.008. No abstract available.

PMID:
28619573
21.

Primary Care-Based Skin Cancer Screening in a Veterans Affairs Health Care System.

Swetter SM, Chang J, Shaub AR, Weinstock MA, Lewis ET, Asch SM.

JAMA Dermatol. 2017 Aug 1;153(8):797-801. doi: 10.1001/jamadermatol.2017.1324.

22.

5-Fluorouracil for Actinic Keratosis Treatment and Chemoprevention: A Randomized Controlled Trial.

Walker JL, Siegel JA, Sachar M, Pomerantz H, Chen SC, Swetter SM, Dellavalle RP, Stricklin GP, Qureshi AA, DiGiovanna JJ, Weinstock MA.

J Invest Dermatol. 2017 Jun;137(6):1367-1370. doi: 10.1016/j.jid.2016.12.029. No abstract available.

23.

Evaluation of photoaging scales in an elderly male population.

Korgavkar K, Weinstock MA, Lee KC; VAKCC Trial Group.

J Eur Acad Dermatol Venereol. 2017 Nov;31(11):e489-e490. doi: 10.1111/jdv.14330. Epub 2017 Jun 20. No abstract available.

PMID:
28500658
24.

Contribution of health care factors to the burden of skin disease in the United States.

Lim HW, Collins SAB, Resneck JS Jr, Bolognia JL, Hodge JA, Rohrer TA, Van Beek MJ, Margolis DJ, Sober AJ, Weinstock MA, Nerenz DR, Smith Begolka W, Moyano JV.

J Am Acad Dermatol. 2017 Jun;76(6):1151-1160.e21. doi: 10.1016/j.jaad.2017.03.006. Epub 2017 Apr 18.

PMID:
28427793
25.

Spectrum of Immune-Related Conditions Associated with Risk of Keratinocyte Cancers among Elderly Adults in the United States.

Yanik EL, Pfeiffer RM, Freedman DM, Weinstock MA, Cahoon EK, Arron ST, Chaloux M, Connolly MK, Nagarajan P, Engels EA.

Cancer Epidemiol Biomarkers Prev. 2017 Jul;26(7):998-1007. doi: 10.1158/1055-9965.EPI-17-0003. Epub 2017 Apr 4.

PMID:
28377416
26.

Temporal trends in healthcare utilization following primary melanoma diagnosis among Medicare beneficiaries.

Lott JP, Wang Q, Titus LJ, Onega T, Nelson HD, Weinstock MA, Elmore JG, Tosteson ANA.

Br J Dermatol. 2017 Sep;177(3):845-853. doi: 10.1111/bjd.15530. Epub 2017 Jul 9.

PMID:
28369774
27.

The global burden of melanoma: results from the Global Burden of Disease Study 2015.

Karimkhani C, Green AC, Nijsten T, Weinstock MA, Dellavalle RP, Naghavi M, Fitzmaurice C.

Br J Dermatol. 2017 Jul;177(1):134-140. doi: 10.1111/bjd.15510. Epub 2017 Jun 12.

28.

The burden of skin disease in the United States.

Lim HW, Collins SAB, Resneck JS Jr, Bolognia JL, Hodge JA, Rohrer TA, Van Beek MJ, Margolis DJ, Sober AJ, Weinstock MA, Nerenz DR, Smith Begolka W, Moyano JV.

J Am Acad Dermatol. 2017 May;76(5):958-972.e2. doi: 10.1016/j.jaad.2016.12.043. Epub 2017 Mar 1.

PMID:
28259441
29.

A Large Skin Cancer Screening Quality Initiative: Description and First-Year Outcomes.

Ferris LK, Saul MI, Lin Y, Ding F, Weinstock MA, Geller AC, Yuan JM, Neuren E, Maddukuri S, Solano FX, Kirkwood JM.

JAMA Oncol. 2017 Aug 1;3(8):1112-1115. doi: 10.1001/jamaoncol.2016.6779.

PMID:
28241191
30.

Predictors of actinic keratosis count in patients with multiple keratinocyte carcinomas: A cross-sectional study.

Siegel JA, Luber AJ, Weinstock MA; Department of Veterans Affairs Topical Tretinoin Chemoprevention Trial and Department of Veterans Affairs Keratinocyte Carcinoma Chemoprevention Trial Groups.

J Am Acad Dermatol. 2017 Feb;76(2):346-349. doi: 10.1016/j.jaad.2016.09.020. No abstract available.

PMID:
28088997
31.

Interval cancers after skin cancer screening: incidence, tumour characteristics and risk factors for cutaneous melanoma.

Hübner J, Waldmann A, Geller AC, Weinstock MA, Eisemann N, Noftz M, Bertram S, Nolte S, Volkmer B, Greinert R, Breitbart E, Katalinic A.

Br J Cancer. 2017 Jan 17;116(2):253-259. doi: 10.1038/bjc.2016.390. Epub 2016 Nov 29.

32.

The influence of tumor regression, solar elastosis, and patient age on pathologists' interpretation of melanocytic skin lesions.

Titus L, Barnhill RL, Lott JP, Piepkorn MW, Elder DE, Frederick PD, Nelson HD, Carney PA, Knezevich SR, Weinstock MA, Elmore JG.

Lab Invest. 2017 Feb;97(2):187-193. doi: 10.1038/labinvest.2016.120. Epub 2016 Nov 28.

33.

Mortality burden and prognosis of thin melanomas overall and by subcategory of thickness, SEER registry data, 1992-2013.

Landow SM, Gjelsvik A, Weinstock MA.

J Am Acad Dermatol. 2017 Feb;76(2):258-263. doi: 10.1016/j.jaad.2016.10.018. Epub 2016 Nov 22.

PMID:
27887797
34.

Reply to 'A phase II randomized controlled trial of nicotinamide for skin cancer chemoprevention in renal transplant recipients'.

Yélamos O, Halpern AC, Weinstock MA.

Br J Dermatol. 2017 Feb;176(2):551-552. doi: 10.1111/bjd.15203. Epub 2017 Jan 23. No abstract available.

PMID:
27880000
35.

Variation among pathologists' treatment suggestions for melanocytic lesions: A survey of pathologists.

Lee KC, Peacock S, Weinstock MA, Zhao GA, Knezevich SR, Elder DE, Barnhill RL, Piepkorn MW, Reisch LM, Carney PA, Onega T, Lott JP, Elmore JG.

J Am Acad Dermatol. 2017 Jan;76(1):121-128. doi: 10.1016/j.jaad.2016.07.029. Epub 2016 Sep 28.

36.

Reply: "Risk of subsequent melanoma after melanoma in situ and invasive melanoma: A population-based study from 1973 to 2011".

Pomerantz H, Weinstock MA.

J Am Acad Dermatol. 2016 Oct;75(4):e165. doi: 10.1016/j.jaad.2016.06.025. No abstract available.

PMID:
27646767
37.

Skin biopsy utilization and melanoma incidence among Medicare beneficiaries.

Weinstock MA, Lott JP, Wang Q, Titus LJ, Onega T, Nelson HD, Pearson L, Piepkorn M, Barnhill RL, Elmore JG, Tosteson ANA.

Br J Dermatol. 2017 Apr;176(4):949-954. doi: 10.1111/bjd.15077. Epub 2017 Mar 1.

38.

Melanoma burden and recent trends among non-Hispanic whites aged 15-49years, United States.

Watson M, Geller AC, Tucker MA, Guy GP Jr, Weinstock MA.

Prev Med. 2016 Oct;91:294-298. doi: 10.1016/j.ypmed.2016.08.032. Epub 2016 Aug 24.

39.

Correlates of skin-related quality of life (QoL) in those with multiple keratinocyte carcinomas (KCs): A cross-sectional study.

Siegel JA, Chren MM, Weinstock MA; Department of Veterans Affairs Keratinocyte Carcinoma Chemoprevention Trial Group.

J Am Acad Dermatol. 2016 Sep;75(3):639-642. doi: 10.1016/j.jaad.2016.05.008. No abstract available.

PMID:
27543222
40.

Male pattern baldness and risk of incident skin cancer in a cohort of men.

Li WQ, Cho E, Han J, Weinstock MA, Qureshi AA.

Int J Cancer. 2016 Dec 15;139(12):2671-2678. doi: 10.1002/ijc.30395. Epub 2016 Sep 8.

41.

Application of Recursive Partitioning to Derive and Validate a Claims-Based Algorithm for Identifying Keratinocyte Carcinoma (Nonmelanoma Skin Cancer).

Chan AW, Fung K, Tran JM, Kitchen J, Austin PC, Weinstock MA, Rochon PA.

JAMA Dermatol. 2016 Oct 1;152(10):1122-1127. doi: 10.1001/jamadermatol.2016.2609.

PMID:
27533718
42.

Current perspective on actinic keratosis: a review.

Siegel JA, Korgavkar K, Weinstock MA.

Br J Dermatol. 2017 Aug;177(2):350-358. doi: 10.1111/bjd.14852. Epub 2016 Aug 8. Review.

PMID:
27500794
43.

Costs of Keratinocyte Carcinoma (Nonmelanoma Skin Cancer) and Actinic Keratosis Treatment in the Veterans Health Administration.

Yoon J, Phibbs CS, Chow A, Pomerantz H, Weinstock MA.

Dermatol Surg. 2016 Sep;42(9):1041-7. doi: 10.1097/DSS.0000000000000820.

PMID:
27465252
44.

Epidemiological Assessments of Skin Outcomes in the Nurses' Health Studies.

Li WQ, Cho E, Weinstock MA, Mashfiq H, Qureshi AA.

Am J Public Health. 2016 Sep;106(9):1677-83. doi: 10.2105/AJPH.2016.303315. Epub 2016 Jul 26. Review.

45.

Visual Inspection and the US Preventive Services Task Force Recommendation on Skin Cancer Screening.

Tsao H, Weinstock MA.

JAMA. 2016 Jul 26;316(4):398-400. doi: 10.1001/jama.2016.9850. No abstract available.

PMID:
27458944
46.

Downstream consequences of melanoma screening in a community practice setting: First results.

Weinstock MA, Ferris LK, Saul MI, Geller AC, Risica PM, Siegel JA, Solano FX, Kirkwood JM.

Cancer. 2016 Oct 15;122(20):3152-3156. doi: 10.1002/cncr.30177. Epub 2016 Jul 8.

47.

Vitamin D at the Expense of Skin Cancer Protection: Is It Worth the Risk?

Thompson JM, Fioletov VE, Marrett LD, Rosen CF, Weinstock MA.

J Invest Dermatol. 2016 Oct;136(10):2104-2105. doi: 10.1016/j.jid.2016.06.012. Epub 2016 Jun 22. No abstract available.

48.

The study of nevi in children: Principles learned and implications for melanoma diagnosis.

Scope A, Marchetti MA, Marghoob AA, Dusza SW, Geller AC, Satagopan JM, Weinstock MA, Berwick M, Halpern AC.

J Am Acad Dermatol. 2016 Oct;75(4):813-823. doi: 10.1016/j.jaad.2016.03.027. Epub 2016 Jun 17. Review.

49.

Cutaneous tumors in pregnancy.

Walker JL, Wang AR, Kroumpouzos G, Weinstock MA.

Clin Dermatol. 2016 May-Jun;34(3):359-67. doi: 10.1016/j.clindermatol.2016.02.008. Epub 2016 Feb 9.

PMID:
27265074
50.

Validation of Photograph-Based Toxicity Score for Topical 5-Fluorouracil Cream Application.

Pomerantz H, Korgavkar K, Lee KC, Lew R, Weinstock MA; VAKCC Trial Group.

J Cutan Med Surg. 2016 Sep;20(5):458-66. doi: 10.1177/1203475416643952. Epub 2016 Apr 18.

PMID:
27207349

Supplemental Content

Loading ...
Support Center